|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print December 4, 2001
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00111.2001
Submitted on March 9, 2001
Accepted on November 14, 2001
1 Hormones and the Vasculature Laboratory, Baker Medical Research Institute, Melbourne, Australia
2 Cell Biology of Diabetes Laboratory, Baker Medical Research Institute, Melbourne, Australia
3 Molecular Signaling Laboratory, Baker Medical Research Institute, Melbourne, Australia
* To whom correspondence should be addressed. E-mail: ksudhir{at}pcyc.com.
We examined effects of 17ß-estradiol (E2) on human vascular smooth muscle cell (VSMC) proliferation under normal (5 mmol/L) and high (25 mmol/L) glucose
concentrations. Platelet-derived growth factor (PDGF) BB (20 ng/mL)- induced increases in DNA synthesis and proliferation were greater in high than normal glucose concentrations; the difference in DNA synthesis was abolished by a protein kinase C (PKC) -ß inhibitor LY379196 (30 nmol/L). Western blotting showed that PKC-ß1 protein increased in cells exposed to high glucose, while PKC-
protein and total PKC activity
remained unchanged, in comparison with normal glucose cultures. In normal glucose, E2(1-100 nmol/L) inhibited PDGF- induced DNA synthesis by 18-37% and cell proliferation
by 16-22% in a concentration-dependent manner. The effects of E2 were blocked by the ER antagonist ICI 182780, indicating ER-dependence. In high glucose, the inhibitory
effect of E2 on VSMC proliferation was abolished, but restored in the presence of the PKC-ß inhibitor LY379196. Thus, high glucose enhances human VSMC proliferation and attenuates the antiproliferative effect of E2 in VSMC via activation of PKC-ß.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |